Fév 2, 2021
January 2021, The president of the Rotary Club of Lyon giving a financial support to Oncofactory to contribute to its innovation program on models of brain tumors. The project is conducted with Professor Jérôme Honnorat and Professor François Ducray of the Hospices...Jan 21, 2021
CONTACT US Discover Oncofactory’s brochure download our flyer Contact-us Web Site NAME * MAIL * PHONE * MESSAGE * I accept the terms of the privacy policy of the website* privacy policy *...Jan 14, 2021
Melanoma program The MelanoPredict project, led by Oncofactory and by Pr Stéphane Dalle, a dermatologist specialized in melanoma, won in 2018 the 2nd Lyonbiopôle / HCL Clinical Innovation Call. The aim of this project is to model sensitivity/resistance to first-line...Jan 14, 2021
Our AVI-PDX™ and AVI-cellDX™ models Oncofactory operates a unique technological platform exploiting an innovative patient-derived xenograft (PDX) animal model, the avian embryo. Miniature replicas of tumors from patient samples (AVI-PDX™) or from cell lines...Jan 14, 2021
ABOUT US The technology of Oncofactory was conceived by Dr. Céline Delloye-Bourgeois and Dr. Valérie Castellani-Lincontang at the NeuroMyoGene Institute in Lyon. The company holds 2 exclusive patent licenses and 1 patent for the platform.Its localization in the... 
Commentaires récents